Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
5-Indolylboronic acid → US9814704, Example 20
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | 5-Indolylboronic acid | HCID 2734361 | — |
| 반응물 | 3,4,5-Trimethoxybenzeneboronic acid | HCID 2734390 | — |
| 반응물 | (2-Aminopyrimidin-5-yl)boronic acid | HCID 17750211 | — |
| 반응물 | 5-bromo-3-iodo-1-tosyl-1H-pyrrolo[2,3-b]pyridine | HCID 49759066 | — |
| 반응물 | 5-bromo-3-(1H-indol-5-yl)-1-tosyl-1H-pyrrolo[2,3-b]pyridine | HCID 66779176 | — |
| 생성물 | US9814704, Example 20 | HCID 66779903 | — |
반응 단계
Compound W was prepared by a method analogous to that described in Example 1 by substituting 2-aminopyrimidin-5-ylboronic acid for 1H-indol-5-ylboronic acid in the reaction with Intermediate A and 2-aminopyrimidin-5-ylboronic acid for 3,4,5-trimethoxyphenylboronic acid in the reaction with Intermediate B. HPLC retention time: 1.17 minutes. MS ESI (m/z): 305.2 (M+H)+, calc. 304.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US08846909B2 |
| 출처 데이터셋 | uspto-grants-2014_09 |
| ORD ID | ord-7bb733119f274e7eb823eb22cb7ce4d2 |
| 출처 메모 | uspto-grants-2014_09 |